Clinical predictors of fetal outcome in systemic lupus erythematosus

Journal of Rheumatology

Volumn 25, Issue 8, 1998, Pages 1526-1530

  Rahman, Proton ^a   Gladman, Dafna D ^b,c   Urowitz, Murray B ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Ctr Prognosis Studs Rheum Dis   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Fetal outcome; Pregnancy; Systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; LUPUS ANTICOAGULANT; METHOTREXATE;

ABORTION; ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; FETUS OUTCOME; HUMAN; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; PERINATAL DEATH; PREDICTION; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; FEMALE; FETAL VIABILITY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK FACTORS;

EID: 0031902341     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bobrie G, Liote F, Houillier P, Greunfield JP, Jungers P. Pregnancy in lupus nephritis and related disorders. Am J Kidney Dis 1987;9:339-43.
2. Fraga A, Mintz G, Orozco J, et al. Sterility and fertility rates, fetal wastage and maternal morbidity in SLE. J Rheumatol 1974;1: 293-8.
3. Houser MT, Fish AJ, Tagatz GE, et al. Pregnancy and SLE. Am J Obstet Gynecol 1980;138:409-13.
4. McHugh NJ, Reilly PA, McHugh LA. Pregnancy outcome and autoantibodies in connective tissue disease. J Rheumatol 1989;16:42-6.
5. Lockshin MD. Pregnancy does not cause SLE to worsen. Arthritis Rheum 1989;32:665-70.
6. Mintz G, Niz J, Gutierrez C, et al. Prospective study in SLE: Results of a multidisciplinary approach. J Rheumatol 1986;13:732-9.
7. Nossent JC, Swaak AJG. SLE: IV. Analysis of the interrelationship with pregnancy. J Rheumatol 1990;17:771-6.
8. Wong KL, Chan FY, Lee CP: Outcome of pregnancy in patients with SLE: A prospective study. Arch Intern Med 1991;151:269-73.
9. Urowitz MB, Gladman DD. Rheumatic diseases in pregnancy. In: Burrows GN, Ferris R, editors. Medical Complications During Pregnancy. Toronto: WB Saunders; 1995.
10. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1992;25:1271-7.
11. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE: Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
12. Gladman DD, Goldsmith CH, Urowitz MB, et al. Sensitivity to change of 3 SLE disease activity indices: International validation: J Rheumatol 1994;21:1468-71.
13. Urowitz MB, Gladman DD, Farewell VT, et al. Lupus and pregnancy studies. Arthritis Rheum 1993;36:1392-7.
14. Petri M, Allbritton J. Fetal outcomes in lupus pregnancy: A retrospective case control study of the Hopkins Lupus Cohort. J Rheumatol 1993;20:650-6.
15. Julkunen H, Jouhikainen T, Kaaja R, et al. Fetal outcomes in lupus pregnancy: A retrospective case control study of 242 pregnancies in 112 patients. Lupus 1993;2:125-31.
16. Le Thi Huong DT, Wechsler B, Piette JC, Bletry O, Godeau P. Pregnancy and its outcomes in SLE. QJM 1994;87:721-9.
17. Lima F, Buchanan N, Khamashta M, Kerslake S, Hughes G. Obstetric outcome in SLE. Semin Arthritis Rheum 1995;25: 184-92.